Sign in
Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis
Journal article   Peer reviewed

Lebrikizumab Provides Stable Itch Response With No or Minimal Fluctuations up to One Year in Patients With Atopic Dermatitis

James Del Rosso, Gil Yosipovitch, Sonja Ständer, Jonathan Silverberg, Andreas Wollenberg, Peter A. Lio, Jose Manuel Carrascosa, Gaia Gallo, Marta Casillas, Evangeline Pierce, …
Skin (Milwood, N.Y.), Vol.7(6), p.s282
2023-11-13

Metrics

1 Record Views

Details